Neale MH - Search Results

1

Comparison of the ex vivo chemosensitivity of uveal and cutaneous melanoma.

Neale MH, Myatt NE, Khoury GG, Weaver P, Lamont A, Hungerford JL, Kurbacher CM, Hall P, Corrie PG, Cree IA. Neale MH, et al. Melanoma Res. 2001 Dec;11(6):601-9. doi: 10.1097/00008390-200112000-00006. Melanoma Res. 2001. PMID: 11725206

2

The chemosensitivity profile of retinoblastoma.

Di Nicolantonio F, Neale M, Onadim Z, Hungerford JL, Kingston JL, Cree IA. Di Nicolantonio F, et al. Recent Results Cancer Res. 2003;161:73-80. doi: 10.1007/978-3-642-19022-3_7. Recent Results Cancer Res. 2003. PMID: 12528800

3

Combination chemotherapy for choroidal melanoma: ex vivo sensitivity to treosulfan with gemcitabine or cytosine arabinoside.

Neale MH, Myatt N, Cree IA, Kurbacher CM, Foss AJ, Hungerford JL, Plowman PN. Neale MH, et al. Br J Cancer. 1999 Mar;79(9-10):1487-93. doi: 10.1038/sj.bjc.6690237. Br J Cancer. 1999. PMID: 10188895 Free PMC article.

4

Heterogeneity of chemosensitivity of metastatic cutaneous melanoma.

Cree IA, Neale MH, Myatt NE, de Takats PG, Hall P, Grant J, Kurbacher CM, Reinhold U, Neuber K, MacKie RM, Chana J, Weaver PC, Khoury GG, Sartori C, Andreotti PE. Cree IA, et al. Among authors: neale mh. Anticancer Drugs. 1999 Jun;10(5):437-44. doi: 10.1097/00001813-199906000-00002. Anticancer Drugs. 1999. PMID: 10477162

5

Ex vivo activity of XR5000 against solid tumors.

Neale MH, Charlton PA, Cree IA. Neale MH, et al. Anticancer Drugs. 2000 Jul;11(6):471-8. doi: 10.1097/00001813-200007000-00008. Anticancer Drugs. 2000. PMID: 11001388

6

Relationship between expression of topoisomerase II isoforms and chemosensitivity in choroidal melanoma.

Satherley K, de Souza L, Neale MH, Alexander RA, Myatt N, Foss AJ, Hungerford JL, Hickson ID, Cree IA. Satherley K, et al. Among authors: neale mh. J Pathol. 2000 Oct;192(2):174-81. doi: 10.1002/1096-9896(2000)9999:9999<::AID-PATH677>3.0.CO;2-H. J Pathol. 2000. PMID: 11004693

7

Abnormalities of the transforming growth factor-beta pathway in ocular melanoma.

Myatt N, Aristodemou P, Neale MH, Foss AJ, Hungerford JL, Bhattacharya S, Cree IA. Myatt N, et al. Among authors: neale mh. J Pathol. 2000 Dec;192(4):511-8. doi: 10.1002/1096-9896(2000)9999:9999<::AID-PATH778>3.0.CO;2-B. J Pathol. 2000. PMID: 11113869

8

The ex vivo effect of high concentrations of doxorubicin on recurrent ovarian carcinoma.

Neale MH, Lamont A, Hindley A, Kurbacher CM, Cree IA. Neale MH, et al. Anticancer Drugs. 2000 Nov;11(10):865-71. doi: 10.1097/00001813-200011000-00011. Anticancer Drugs. 2000. PMID: 11142695

9

Uveal melanomas express vascular endothelial growth factor and basic fibroblast growth factor and support endothelial cell growth.

Boyd SR, Tan DS, de Souza L, Neale MH, Myatt NE, Alexander RA, Robb M, Hungerford JL, Cree IA. Boyd SR, et al. Among authors: neale mh. Br J Ophthalmol. 2002 Apr;86(4):440-7. doi: 10.1136/bjo.86.4.440. Br J Ophthalmol. 2002. PMID: 11914215 Free PMC article.

10

Use of an ATP-based chemosensitivity assay to design new combinations of high-concentration doxorubicin with other drugs for recurrent ovarian cancer.

Di Nicolantonio F, Neale MH, Knight LA, Lamont A, Skailes GE, Osborne RJ, Allerton R, Kurbacher CM, Cree IA. Di Nicolantonio F, et al. Among authors: neale mh. Anticancer Drugs. 2002 Jul;13(6):625-30. doi: 10.1097/00001813-200207000-00009. Anticancer Drugs. 2002. PMID: 12172508

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page